---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-007057"
form_type: "8-K/A"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2023-10-11T23:59:59+00:00"
generated_at: "2026-06-10T01:33:43.160231+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals files amended 8-K with updated investor presentation; no material new information

## Summary
- Amended filing corrects item number from original 8-K dated October 11, 2023.
- Investor presentation (October 2023) describes stabilized hypochlorous acid products for dermatology, wound care, etc.
- Products are sold directly or via partners in 55 countries; company actively seeks distribution partners.
- Presentation contains no financial results, guidance, or material operational updates.

## SEC filing metadata
- accession: 0001683168-23-007057
- form_type: 8-K/A
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2023-10-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316823007057/0001683168-23-007057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316823007057/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-007057
- JSON: https://secwatch.observer/filing/0001683168-23-007057.json
- Plain text: https://secwatch.observer/filing/0001683168-23-007057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.